OPINION | China’s laissez-faire approach to cutting edge medical technology has set the cat among the...

A Chinese company engaged in semi-invasive brain-computer interface became the first firm globally to get regulatory approval for commercial use. It took a mere 12 days for multiple clearances, including hospital procurement. The US regulatory framework will feel its impact